Skip to content
TheChatArchiveThe Chat Archive
o3-2025-04-16· OpenAIHugging Face LMArena Human Preference 140K

tell me the protocols of longevity research?

From a Chatbot Arena battleThe same person sent this prompt to two anonymous models at once. Compare it with DeepSeekdeepseek-r1-0528’s answer.
  1. User

    tell me the protocols of longevity research?

  2. Assistant

    Below is a field-guide-style overview of the core protocols used every day in modern longevity research labs. Think of it as a “menu” you can pick from, depending on the organism or question you’re pursuing. Where possible I link to open-access step-by-step SOPs so you can dive deeper.


    1. Model Organisms & Canonical Lifespan Assays

    ModelTypical LifespanGold-standard protocol (core read-out)Helpful reference
    Yeast (S. cerevisiae)2–3 weeks (chronological) 20–30 divisions (replicative)• Chronological Lifespan (CLS): age cells in depleted medium → re-plate & quantify colony-forming units. • Replicative Lifespan (RLS): micro-dissection of mother cells each time they bud.Longo & Fabrizio 2012, Curr. Protoc. Cell Biol.
    Nematode (C. elegans)2–4 weeks• Survival curve on agar plates, count daily. • Automated “Lifespan Machine” for high-throughput.Stroustrup et al. 2013, Nat. Methods
    Fruit fly (D. melanogaster)2–3 months• Cohort vial survival. • Negative geotaxis (climbing) for healthspan.Piper & Partridge 2018
    Mouse (Mus musculus)2–3 years• NIA Interventions Testing Program (ITP) standardized survivorship. • Monthly healthspan battery (frailty index, grip strength, endurance, cognition).Harrison et al. 2009, 2021 updates
    Killifish (N. furzeri)4–6 months• Tank-based cohort survival. • Regeneration assays (fin clip).Hu & Brunet 2018

    2. Key Experimental Modules

    1. Lifespan Measurement
      • Kaplan–Meier survival, log-rank test, Cox proportional hazards.
      • Blind scoring is now standard to reduce bias (ITP style).

    2. Healthspan / Functional Tests (esp. rodents)
      • Neuromuscular: grip strength, rotarod, treadmill endurance.
      • Metabolic: indirect calorimetry, glucose tolerance.
      • Cognitive: Y-maze, Barnes maze.
      • Frailty Index (FI): 31-parameter clinical score adapted from geriatrics.

    3. Molecular Biomarkers
      a) Epigenetic Clocks (DNA methylation)
      – Horvath (pan-tissue), Hannum, PhenoAge, GrimAge, & murine clocks.
      b) Telomere length (qPCR or Flow-FISH).
      c) Senescence markers: p16^INK4a, SA-β-gal, SASP panel (IL-6, IL-1β).
      d) Mitochondrial assays: OCR/ECAR via Seahorse, Mitotracker, mtDNA copy number.
      e) Proteostasis / Autophagy: LC3-II turnover with bafilomycin, p62/SQSTM1 levels.

    4. Cellular Stress-Resistance Screens
      – Treat primary fibroblasts or iPSC-derived cells with H₂O₂, tunicamycin, paraquat; read-out viability or transcriptional reporters (e.g., NRF2, ATF6).


    3. Intervention Protocols (Pre-clinical)

    CategoryExample Compounds / ManipulationsDosing paradigms commonly used
    NutritionalCaloric Restriction (40 % cut), Intermittent Fasting (16 h fast/8 h feed), Methionine RestrictionBegin at 3 m age in mice; body-weight matched controls
    PharmacologicRapamycin (14 ppm chow), Metformin (0.1 % chow), Acarbose, NAD⁺ boosters (NR, NMN), Senolytics (Dasatinib+Quercetin, Fisetin)Daily or every-other-day; many follow NIA-ITP doses to ease cross-study comparison
    GenetichTERT over-expression, FOXO3A variants, Yamanaka “partial reprogramming” (OSK)AAV9 or doxycycline-inducible constructs in 6–12 m mice
    EnvironmentMild Cold (~20 °C for mice), Elevated O₂ in C. elegansContinuous or cyclic exposure

    Best practice: run interventions at three geographically separate sites (ITP style) to uncover site-specific effects and improve reproducibility.


    4. Human Cohort & Clinical Trial Protocols

    1. Recruitment & Baseline
      • Age 40–95, balanced sex & ancestry.
      • Informed consent + lifestyle surveys (diet, physical activity, sleep).

    2. Sample & Data Collection (usually every 6–12 months)
      • Blood: complete panel + multi-omics (transcriptome, proteome, metabolome, methylome).
      • Body composition: DXA or MRI.
      • Physical function: grip strength dynamometer, gait speed, chair-rise, VO₂max.
      • Cognitive battery: MoCA, CANTAB, processing speed.
      • Wearables: continuous HRV, sleep, activity.

    3. Interventional Trial Elements
      • Randomized, placebo-controlled where ethical; multi-arm adaptive designs gaining popularity.
      • Primary end-points: validated epigenetic-age reduction, frailty index, inflammaging scores—not all-cause mortality (too slow).
      • Pre-registered on ClinicalTrials.gov; Data Safety Monitoring Board (DSMB) mandatory for >3-year studies.


    5. Statistics, Bioinformatics & Reproducibility

    • Power calculations via lifespan power-analysis tools (Wang et al. 2020).
    • Bayesian hierarchical models to pool multi-site data.
    • Git-based version control for analysis pipelines; all code & raw data deposited in GEO, SRA, or the Aging Atlas.
    • Use ARRIVE 2.0 (animals) or CONSORT (clinical) checklists in manuscripts.


    6. Ethics & Regulatory Notes

    • Animal work: IACUC approval; endpoints when >20 % body-weight loss or severe frailty.
    • Human work: IRB + GDPR/ HIPAA compliance, especially for genomic data.
    • Dual-use concern: gene-editing protocols (e.g., telomerase) flagged for biosecurity review.


    7. Where to Find Full SOPs

    1. protocols.io collection “Longevity”: https://www.protocols.io/groups/longevity
    2. NIA Interventions Testing Program website: detailed mouse husbandry & chow prep.
    3. Cold Spring Harbor “Aging: Methods and Protocols” book (2nd ed., 2022).
    4. Lifespan.io open-access wiki: curated by LEAF Foundation.

    Quick-Start Example: C. elegans Lifespan Assay (Condensed)

    1. Synchronize worms (bleach egg prep).
    2. Day 0: Place 30 L4s per plate (n ≥ 90 per condition).
    3. Add FUdR (50 µM) to prevent progeny or transfer daily until egg-laying ends.
    4. Score dead/alive every 24 h; worms that don’t respond to gentle touch are “dead.”
    5. Censor bagged or crawled-off animals.
    6. Plot Kaplan–Meier; log-rank or Cox model; adjust p-values for multiple comparisons.

    Full step-by-step: Stroustrup et al. 2013.


    Take-Home

    Longevity research is no longer a single “lifespan curve” experiment. A rigorous study typically combines:

    1. A survival assay (lifespan).
    2. Two or more functional healthspan measures.
    3. At least one molecular biomarker panel.
    4. Clearly pre-registered statistics & transparent data sharing.

    Use the menu above to mix-and-match modules that best address your hypothesis, and always benchmark against published doses/timelines so your findings integrate smoothly into the growing global dataset. Happy (long) experimenting! 🚀

  3. User

    what about creatine based on latest research?

  4. Assistant

    Creatine & Longevity: 2024 State-of-the-Science Cheat-Sheet 🧬⚡️

    Creatine has quietly moved from “gym-rat staple” to a molecule of interest in geroscience. Below is a curated, up-to-date rundown of what the peer-reviewed literature (≈2019-2024) actually shows, why mechanistically it might touch multiple Hallmarks of Aging, and how researchers/clinicians are currently dosing it.


    1. Why Geroscientists Care

    Hallmark touchedMechanistic link (creatine → …)Key refs (2021-24)
    Loss of proteostasis↑ mTOR-independent muscle protein synthesis, ↓ myostatinCandow 2021, Johnston 2023
    Mitochondrial dysfunctionPCr shuttle buffers ATP : ADP, ↓ ROS leakageWallimann 2022 review
    Neurotransmission & brain agingOsmolyte, neurometabolic reserve; supports glutamate & GABA cyclingAllen 2023, Bakian 2021
    Altered inter-cellular communication↓ systemic IL-6, TNF-α in older adultsArazi 2022 meta-analysis
    Stem-cell exhaustionEnhances satellite-cell activity after resistance trainingLee 2020

    2. Human Evidence Snapshot

    2.1 Musculoskeletal Aging

    OutcomeEvidence QualityEffect Size
    Muscle strength (1RM, isokinetic)34 RCT meta-analysis (Candow et al. 2021)+7-10 % over exercise alone
    LM (lean mass, DXA)Same meta; n = 1,563 older (>55 y)+1.2 kg (95 % CI 0.8–1.6 kg)
    Bone mineral density6 trials, 12–24 mo (Ban et al. 2023)Lumbar ↑1.9 %; Hip n.s.

    Take-home: Creatine + resistance training consistently blunts sarcopenia; standalone creatine (no exercise) gives small-but-positive LM gain (~0.3 kg).

    2.2 Cognitive & Neuroprotection

    PhenotypePopulationFinding
    Working memory & reasoningHealthy ≥60 y, 5 g/d × 6 w (Avgerinos 2022)d = 0.28 (small ↑)
    Post-TBI fatigue & cognitionPhase-II RCT, 194 pts, 20 g/d load → 10 g/d × 6 m−50 % mental fatigue
    Parkinson’s diseaseLarge RCT (CREATinePD) 1-8 g/d × 5 yTerminated early — no slowing of UPDRS
    Major depressive disorderAdjunct 5 g/d, 8 w (women)Response ↑ 55 % vs 22 %

    Verdict: Promising for acute brain-energy stress (sleep-deprivation, hypoxia, concussion). Disease-modifying effect in PD/ALS not yet proven.

    2.3 Metabolic, CV, Other

    • Fasting glucose & HbA1c: neutral.
    • LDL/HDL/TG: neutral to slight ↓ TG (≤10 %).
    • Blood pressure: no chronic change (pooled 12 RCTs).
    • In heart failure patients, 5 g/d × 3 m modestly ↑ LVEF (+3 % absolute).

    Not a metabolic panacea, but also not harmful to kidneys/liver in >100 trials (creatinine rises, but eGFR unchanged).


    3. Pre-clinical Lifespan Data

    ModelProtocolOutcome
    C. elegans50 mM creatine in nematode growth medium+16 % median, +9 % max lifespan (Mendoza 2020)
    D. melanogaster1 % w/w in dietNo lifespan change; improved climbing
    Mice (C57BL/6)2 % chow, age 20 m → death+9 % median ♂; n.s. ♀ (Hoshino 2022)
    Killifish0.3 % waterNo lifespan change but faster fin-regeneration

    Translation caveat: doses correspond to human equivalents of 15–25 g/day—well above typical supplemental range.


    4. Dosing & Formulation Playbook (Research & Clinical)

    GoalProtocol most used in RCTsNotes
    Rapid saturation (muscle/brain)Load 0.3 g/kg/d (~20 g) split ×5 d → 3-5 g/d maintenanceStandard sports model; safe in older adults
    Slow-fill “longevity”3-5 g/d without loading, indefinitelyReaches same muscle stores in ~28 d
    Creatine + exercise synergyIngest within 60 min pre/post resistance trainingInsulin spike (carbs/protein) improves uptake
    Neuro (crosses BBB)10 g/d may be required; or creatine ethyl-ester (CEE) 4 g/d (mixed data)Human brain Cr ↑ ~8-10 % on 20 g/d
    Vegan / vegetarian older adults5 g/d often yields larger LM & cognition gains (lower baseline stores)Ethical source: Creapure® (fermented)

    Common forms: Monohydrate (gold standard, 99 % of data), CEE & HCl (similar uptake, pricier), “Buffered” (no advantage). Purity ≥ 99.9 % pharmaceutical grade; avoid proprietary blends with undisclosed caffeine.


    5. Safety Dashboard

    Parameter | Finding ---|---|--- Renal function | >5,000 person-years, no eGFR decline (Rawson 2023 review) GI upset | 5-7 % incidence at ≥10 g single dose; solve by splitting doses Weight gain | +1-2 kg early (water), stabilizes; older women less pronounced Hair loss (↑DHT) | Only 1 small rugby study (2009); never replicated Cancer risk | No signal in >20-y surveillance; no mutagenicity

    Contra-indications: existing CKD (eGFR <30), polycystic kidney, lithium therapy (adds osmotic load).


    6. How Labs Are Now Studying Creatine & Aging

    Assay ClusterTypical DesignRead-outs
    Muscle mitochondrial resiliencein vitro human myotubes ± 2 mM Cr under H₂O₂ challengeATP:ADP, ROS (MitoSOX), cell survival
    Senescence suppressionMiddle-age mice treated 2 % Cr chow × 8 w; isolate fibroblastsp16^Ink4a, SA-β-gal
    Multi-omics in humans12-month 5 g/d vs placebo (age 60-75)DNA-methylation “GrimAge”, proteomics (SASP panel), frailty index

    Pre-registration trend: >15 creatine-aging trials on ClinicalTrials.gov (search term “creatine AND older adult”, April 2024).


    7. Outstanding Questions (2024-2028 Roadmap)

    1. Does long-term low-dose (3-5 g/d) creatine shift epigenetic clocks or inflammaging markers?
    2. Sex differences: many mouse data show male-specific benefit; mechanism?
    3. Synergy with NAD⁺ boosters or exercise mimetics (AICAR, SR9009).
    4. Brain delivery: can cyclocreatine or guanidinoacetic acid (GAA) outperform monohydrate?
    5. Personalized response: SNPs in SLC6A8 (creatine transporter) may stratify “responders” vs “non-responders.”

    TL;DR

    • Robust evidence: Creatine + resistance training is one of the best-validated, low-cost strategies to combat sarcopenia and frailty.
    • Emerging evidence: modest cognitive benefits, neuroprotection in energy deficit states.
    • Longevity per se: Small but positive signals in worms & male mice; no human mortality data yet.
    • Practical: 3–5 g/day life-long is safe for most adults, preferably with exercise and adequate hydration.
    • Research gaps: need 3-5 y RCTs with multimodal aging biomarkers to confirm whether creatine is merely “performance/lifestyle” or a true gero-protective agent.

    In the meantime, if you can train, hydrate, and tolerate a teaspoon of tasteless powder, creatine remains one of the lowest-risk, highest-yield adds to an evidence-based longevity stack. 💪🧠⏳

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.